IRadimed Corporation (IRMD)
USD 49.54
(-3.54%)
USD 49.54
(-3.54%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 20.73 Million USD | 75.12% |
| 2022 | 11.84 Million USD | 10.58% |
| 2021 | 10.7 Million USD | 10.59% |
| 2020 | 9.68 Million USD | -13.59% |
| 2019 | 11.2 Million USD | 72.47% |
| 2018 | 6.49 Million USD | 6.82% |
| 2017 | 6.08 Million USD | 14.63% |
| 2016 | 5.3 Million USD | 60.23% |
| 2015 | 3.31 Million USD | 36.88% |
| 2014 | 2.41 Million USD | 54.66% |
| 2013 | 1.56 Million USD | -32.99% |
| 2012 | 2.33 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 10.81 Million USD | 5.22% |
| 2024 Q1 | 11.89 Million USD | -42.65% |
| 2024 Q2 | 10.27 Million USD | -13.58% |
| 2023 Q3 | 12.83 Million USD | 3.26% |
| 2023 Q4 | 20.73 Million USD | 61.52% |
| 2023 Q2 | 12.43 Million USD | 10.22% |
| 2023 Q1 | 11.28 Million USD | -4.73% |
| 2023 FY | 20.73 Million USD | 75.12% |
| 2022 Q1 | 9.84 Million USD | -8.06% |
| 2022 Q4 | 11.84 Million USD | 21.16% |
| 2022 FY | 11.84 Million USD | 10.58% |
| 2022 Q3 | 9.77 Million USD | -0.53% |
| 2022 Q2 | 9.82 Million USD | -0.2% |
| 2021 Q3 | 10.5 Million USD | -1.6% |
| 2021 Q2 | 10.67 Million USD | 17.2% |
| 2021 FY | 10.7 Million USD | 10.59% |
| 2021 Q4 | 10.7 Million USD | 1.91% |
| 2021 Q1 | 9.11 Million USD | -5.9% |
| 2020 Q4 | 9.68 Million USD | -0.27% |
| 2020 FY | 9.68 Million USD | -13.59% |
| 2020 Q3 | 9.7 Million USD | -7.19% |
| 2020 Q2 | 10.46 Million USD | 1.49% |
| 2020 Q1 | 10.3 Million USD | -8.01% |
| 2019 Q2 | 9.69 Million USD | -0.72% |
| 2019 Q3 | 10.79 Million USD | 11.36% |
| 2019 Q4 | 11.2 Million USD | 3.76% |
| 2019 FY | 11.2 Million USD | 72.47% |
| 2019 Q1 | 9.76 Million USD | 50.34% |
| 2018 Q3 | 6.71 Million USD | 0.82% |
| 2018 Q2 | 6.66 Million USD | 10.63% |
| 2018 Q4 | 6.49 Million USD | -3.32% |
| 2018 FY | 6.49 Million USD | 6.82% |
| 2018 Q1 | 6.02 Million USD | -0.95% |
| 2017 Q1 | 5.39 Million USD | 1.61% |
| 2017 Q4 | 6.08 Million USD | 5.23% |
| 2017 FY | 6.08 Million USD | 14.63% |
| 2017 Q3 | 5.77 Million USD | 4.18% |
| 2017 Q2 | 5.54 Million USD | 2.9% |
| 2016 Q3 | 4.84 Million USD | 24.91% |
| 2016 Q4 | 5.3 Million USD | 9.49% |
| 2016 Q1 | 4.2 Million USD | 27.03% |
| 2016 FY | 5.3 Million USD | 60.23% |
| 2016 Q2 | 3.87 Million USD | -7.77% |
| 2015 FY | 3.31 Million USD | 36.88% |
| 2015 Q2 | 3.67 Million USD | 20.66% |
| 2015 Q1 | 3.04 Million USD | 25.87% |
| 2015 Q4 | 3.31 Million USD | 12.74% |
| 2015 Q3 | 2.93 Million USD | -20.06% |
| 2014 Q1 | 1.64 Million USD | 5.33% |
| 2014 Q3 | 2.26 Million USD | -14.23% |
| 2014 FY | 2.41 Million USD | 54.66% |
| 2014 Q4 | 2.41 Million USD | 7.01% |
| 2014 Q2 | 2.63 Million USD | 59.99% |
| 2013 FY | 1.56 Million USD | -32.99% |
| 2013 Q4 | 1.56 Million USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | 2.33 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 59.543% |
| BrainsWay Ltd. | 15.31 Million USD | -35.405% |
| Cerus Corporation | 144.3 Million USD | 85.63% |
| Envoy Medical, Inc. | 9.4 Million USD | -120.548% |
| electroCore, Inc. | 8.94 Million USD | -131.816% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -288.168% |
| IceCure Medical Ltd | 4.24 Million USD | -388.249% |
| Inogen, Inc. | 121.38 Million USD | 82.917% |
| OrthoPediatrics Corp. | 72.56 Million USD | 71.423% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 29.901% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -551.675% |
| MaxCyte, Inc. | 36.1 Million USD | 42.571% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -1022.129% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -4775.82% |
| Orthofix Medical Inc. | 326.58 Million USD | 93.651% |
| PAVmed Inc | 57.13 Million USD | 63.708% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 18.564% |
| RxSight, Inc. | 22.18 Million USD | 6.544% |
| Sight Sciences, Inc. | 46.43 Million USD | 55.345% |
| SI-BONE, Inc. | 61.05 Million USD | 66.035% |
| TELA Bio, Inc. | 59.16 Million USD | 64.954% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 81.806% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -100.949% |
| Acutus Medical, Inc. | 54.83 Million USD | 62.188% |
| Talis Biomedical Corporation | 29.22 Million USD | 29.045% |
| Spectral AI, Inc. | 12.4 Million USD | -67.212% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 10.366% |
| CVRx, Inc. | 39.28 Million USD | 47.213% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -73.405% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -753.577% |
| Bioventus Inc. | 589.79 Million USD | 96.484% |
| Venus Concept Inc. | 107.1 Million USD | 80.639% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 59.863% |
| LivaNova PLC | 1.15 Billion USD | 98.2% |
| 908 Devices Inc. | 37.49 Million USD | 44.689% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 97.052% |
| Nemaura Medical Inc. | 26.37 Million USD | 21.388% |
| NeuroPace, Inc. | 86.99 Million USD | 76.165% |
| LENSAR, Inc. | 22.4 Million USD | 7.466% |
| Apyx Medical Corporation | 52.31 Million USD | 60.366% |
| Cutera, Inc. | 518.12 Million USD | 95.998% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 29.296% |
| BioSig Technologies, Inc. | 4.68 Million USD | -342.603% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 64.473% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 3.5% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.055% |
| Axonics, Inc. | 82.35 Million USD | 74.823% |
| Outset Medical, Inc. | 190.91 Million USD | 89.139% |
| IRIDEX Corporation | 24.91 Million USD | 16.77% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 83.273% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -1138.706% |
| INVO Bioscience, Inc. | 19.99 Million USD | -3.706% |
| Telesis Bio, Inc. | 40.87 Million USD | 49.267% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 49.164% |
| Varex Imaging Corporation | 668.6 Million USD | 96.899% |
| Quipt Home Medical Corp. | 136.29 Million USD | 84.786% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -480.513% |
| Pulmonx Corporation | 60.63 Million USD | 65.803% |
| Dynatronics Corporation | 11.78 Million USD | -76.025% |
| Modular Medical, Inc. | 2.27 Million USD | -812.673% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -410.235% |
| Semler Scientific, Inc. | 6.27 Million USD | -230.717% |
| InMode Ltd. | 75.91 Million USD | 72.685% |
| Bruker Corporation | 2.83 Billion USD | 99.269% |
| Cytosorbents Corporation | 29.98 Million USD | 30.847% |
| DexCom, Inc. | 4.19 Billion USD | 99.506% |
| Align Technology, Inc. | 2.45 Billion USD | 99.155% |
| Viveve Medical, Inc. | 10.84 Million USD | -91.167% |
| ZimVie Inc. | 795.85 Million USD | 97.394% |
| Movano Inc. | 5.97 Million USD | -247.219% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 80.177% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -4775.82% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -73.405% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 96.755% |
| Profound Medical Corp. | 12.66 Million USD | -63.715% |
| Insulet Corporation | 1.85 Billion USD | 98.882% |
| enVVeno Medical Corporation | 2.43 Million USD | -751.578% |
| Surmodics, Inc. | 65.82 Million USD | 68.497% |
| iCAD, Inc. | 8 Million USD | -159.167% |
| Nuwellis, Inc. | 6.78 Million USD | -205.84% |
| Biotricity, Inc. | 35.91 Million USD | 42.271% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 90.703% |
| Aethlon Medical, Inc. | 2.47 Million USD | -736.244% |
| InspireMD, Inc. | 8.14 Million USD | -154.679% |
| PAVmed Inc. | 57.13 Million USD | 63.708% |
| BIOLASE, Inc. | 35.34 Million USD | 41.338% |
| Beyond Air, Inc. | 29.77 Million USD | 30.358% |
| FONAR Corporation | 57.45 Million USD | 63.911% |
| AxoGen, Inc. | 101.16 Million USD | 79.502% |
| Vivani Medical, Inc. | 25.03 Million USD | 17.176% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 76.382% |
| Inari Medical, Inc. | 209.32 Million USD | 90.094% |
| UFP Technologies, Inc. | 118.04 Million USD | 82.434% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -63.397% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -848.66% |
| Tenon Medical, Inc. | 5.56 Million USD | -272.48% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1065.595% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -17.59% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.342% |
| Sintx Technologies, Inc. | 6.59 Million USD | -214.514% |
| NanoVibronix, Inc. | 2.68 Million USD | -672.001% |
| Quanterix Corporation | 78.08 Million USD | 73.444% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -480.513% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -324.482% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 98.015% |
| TransMedics Group, Inc. | 568.84 Million USD | 96.355% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -24.301% |
| NeuroMetrix, Inc. | 1.33 Million USD | -1455.439% |
| Hyperfine, Inc. | 9.8 Million USD | -111.591% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 91.714% |
| Biomerica, Inc. | 2.66 Million USD | -678.668% |
| Bone Biologics Corporation | 831.4 Thousand USD | -2394.092% |
| AVITA Medical, Inc. | 19.86 Million USD | -4.382% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -950.621% |
| Silk Road Medical, Inc | 114.15 Million USD | 81.836% |